Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2006-10-2
pubmed:abstractText
Rheumatoid arthritis (RA) is associated with increased risk for cardiovascular (CV) events through multiple factors. Fish oil has been shown to reduce symptoms in RA and to reduce CV risk. We assessed the effect of an antiinflammatory dose of fish oil on CV risk factors within a program of combination chemotherapy for patients with early RA.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0315-162X
pubmed:author
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1973-9
pubmed:meshHeading
pubmed-meshheading:16881100-Adult, pubmed-meshheading:16881100-Aged, pubmed-meshheading:16881100-Antirheumatic Agents, pubmed-meshheading:16881100-Arachidonic Acid, pubmed-meshheading:16881100-Arthritis, Rheumatoid, pubmed-meshheading:16881100-Cardiovascular Diseases, pubmed-meshheading:16881100-Dietary Supplements, pubmed-meshheading:16881100-Dinoprostone, pubmed-meshheading:16881100-Dose-Response Relationship, Drug, pubmed-meshheading:16881100-Drug Therapy, Combination, pubmed-meshheading:16881100-Eicosanoids, pubmed-meshheading:16881100-Female, pubmed-meshheading:16881100-Fish Oils, pubmed-meshheading:16881100-Humans, pubmed-meshheading:16881100-Hydroxychloroquine, pubmed-meshheading:16881100-Male, pubmed-meshheading:16881100-Methotrexate, pubmed-meshheading:16881100-Middle Aged, pubmed-meshheading:16881100-Risk Factors, pubmed-meshheading:16881100-Sulfasalazine, pubmed-meshheading:16881100-Thromboxane A2
pubmed:year
2006
pubmed:articleTitle
Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.
pubmed:affiliation
Rheumatology Unit, Royal Adelaide Hospital, North Terrace, Adelaide, Australia. lcleland@mail.rah.sa.gov.au
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't